MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

    HS. Lee (Sacramento, USA)

    Objective: Botulinum toxin has been an effective and safe treatment option for hemifacial spasm. This is a report of 5 patients with successful treatment of…
  • 2025 International Congress

    Hemichorea as an Atypical Manifestation of Hypoglycemia: A Rare Case Report

    Y. Raja Morangkey, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

    Objective: To present a rare case of hemichorea as a neurological manifestation of hypoglycemia, highlighting the importance of considering metabolic factors in patients with movement…
  • 2025 International Congress

    Anterior Pallidal Stimulation for Severe Tourette Syndrome: Open Phase Outcomes

    P. Limousin, T. Foltynie, V. Lind, M. Krueger, H. Akram, J. Esperida, C. Milabo, H. Tyagi, D. Bindman, M. Silverdale, G. Auld, H. Sims, K. Chowdhury, N. Ahmed, A. King, L. Zrinzo, E. Joyce (London, United Kingdom)

    Objective: To present the open phase outcomes of a trial of anterior pallidal stimulation (antGPi DBS) on tic severity in patients with severe Tourette syndrome…
  • 2025 International Congress

    Efficacy of Clonidine for Tourette Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

    Y. Aljazi, A. Abunamoos, F. Alnajjar, M. Mustafa, J. Al-Tarawneh, L. Aldaher, M. Alghaniem (Amman, Jordan)

    Objective: To evaluate the efficacy of Clonidine in reducing tic severity and improving global clinical outcomes in patients with Tourette syndrome. Background: Tourette syndrome is a neurodevelopmental disorder…
  • 2025 International Congress

    Phenotypical Study of Progressive Myoclonic Epilepsy in Eastern Algeria

    SM. Behloul, Y. Mecheri, A. Boulefkhad (Constantine, Algeria)

    Objective: We aim to analyze phenotypical features of individuals from eastern Algeria having a PME phenotype followed in our center (Dr Benbadis University Hospital). Background:…
  • 2025 International Congress

    Compound Heterozygous VPS13A Variants in a Chilean Chorea-Acanthocytosis Patient

    P. Meza Castro, P. Saffie Awad, E. Fernández Toledo (Concepción, Chile)

    Objective: To present a clinical case of a Chilean ChAC patient with a new compound heterozygous VPS13A variant. Background: Neuroacanthocytosis is a group of genetic…
  • 2025 International Congress

    MDS Task Force on Tic Disorders: Development of a New Classification Scheme for Tic Disorders

    I. Malaty, K. Bhatia, K. Black, F. Cardoso, D. Gilbert, M. Hallett, J. Jimenez-Shahed, D. Martino, A. Munchau, M. Okun, P. Pal, J. Piacentini, T. Pringsheim, Y. Worbe, C. Ganos (London, United Kingdom)

    Objective: To establish a clear definition and axis classification scheme for tics that serves to separate phenomenology from etiology. Background: Gilles de la Tourette documented…
  • 2025 International Congress

    Dual Target Bi Pallidal Deep Brain Stimulation in Tourette Syndrome Deciphering Neurophysiology with Chronic Local Field Potential Recordings

    O. Gonul Oner, A. Castrioto, M. Perreira, S. Meoni, P. Pellisier, S. Chabardes, E. Moro (Grenoble, France)

    Objective: To investigate the neurophysiological activity of dual-target bi-pallidal DBS in Tourette Syndrome (TS) patients using chronic local field potential (LFP) recordings in an outpatient…
  • 2025 International Congress

    Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study

    E. Dunayevich, A. Parameswaran, M. Bron, E. Franey, D. Sparta, C. Zeng, S. Mathias, J. Mcevoy (San Diego, USA)

    Objective: To evaluate the effects of once-daily valbenazine (VBZ) on the impacts of tardive dyskinesia (TD) using multiple patient-reported outcomes (PROs), including the psychometrically validated…
  • 2025 International Congress

    A Unique Case of Reverse Hemifacial Spasm Reproducible Upon Neck Extension

    S. Lee, A. Ohno, K. Frei (Loma Linda, USA)

    Objective: To describe an anatomical mechanism of reverse hemifacial spasm (RHFS) inducible with neck extension. Background: Hemifacial spasm (HFS) is a movement disorder often caused…
  • « Previous Page
  • 1
  • …
  • 232
  • 233
  • 234
  • 235
  • 236
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley